Abu-Halima M, Wagner V, Becker LS, Ayesh BM, Abd El-Rahman M, Fischer U, Meese E, Abdul-Khaliq H (2021) Integrated microRNA and mRNA expression profiling identifies novel targets and networks associated with ebstein's anomaly. Cells 10. https://doi.org/10.3390/cells10051066

Awadalla A, Abol-Enein H, Hamam ET, Ahmed AE, Khirallah SM, El-Assmy A, Mostafa SA, Babalghith AO, Ali M, Abdel-Rahim M, Shokeir AA, Harraz AM (2022) Identification of epigenetic interactions between miRNA and gene expression as potential prognostic markers in bladder cancer. Genes (Basel) 13. https://doi.org/10.3390/genes13091629.

Brahmer J, Reckamp KL, Baas P, Crino L, Eberhardt WE, Poddubskaya E, Antonia S, Pluzanski A, Vokes EE, Holgado E, Waterhouse D, Ready N, Gainor J, ArenFrontera O, Havel L, Steins M, Garassino MC, Aerts JG, Domine M, Paz-Ares L, Reck M, Baudelet C, Harbison CT, Lestini B, Spigel DR (2015) Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med 373:123–135. https://doi.org/10.1056/NEJMoa1504627

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK (2014) Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer 14:535–546. https://doi.org/10.1038/nrc3775

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen G, Hu J, Huang Z, Yang L, Chen M (2016) MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1. Biochem Biophys Res Commun 473:1144–1151. https://doi.org/10.1016/j.bbrc.2016.04.030

Article  PubMed  CAS  Google Scholar 

Chen C, Tang J, Xu S, Zhang W, Jiang H (2020) miR-30a-5p inhibits proliferation and migration of lung squamous cell carcinoma cells by targeting FOXD1. Biomed Res Int 2020:2547902. https://doi.org/10.1155/2020/2547902

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cheng Z, Yu C, Cui S, Wang H, Jin H, Wang C, Li B, Qin M, Yang C, He J, Zuo Q, Wang S, Liu J, Ye W, Lv Y, Zhao F, Yao M, Jiang L, Qin W (2019) circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nat Commun 10:3200. https://doi.org/10.1038/s41467-019-11162-4

Article  PubMed  PubMed Central  CAS  Google Scholar 

Denisenko TV, Budkevich IN, Zhivotovsky B (2018) Cell death-based treatment of lung adenocarcinoma. Cell Death Dis 9:117. https://doi.org/10.1038/s41419-017-0063-y

Article  PubMed  PubMed Central  Google Scholar 

Duma N, Santana-Davila R, Molina JR (2019) Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin Proc 94:1623–1640. https://doi.org/10.1016/j.mayocp.2019.01.013

Article  PubMed  CAS  Google Scholar 

Hai J, Zhang H, Zhou J, Wu Z, Chen T, Papadopoulos E, Dowling CM, Pyon V, Pan Y, Liu JB, Bronson RT, Silver H, Lizotte PH, Deng J, Campbell JD, Sholl LM, Ng C, Tsao MS, Thakurdin C, Bass AJ, Wong KK (2020) Generation of genetically engineered mouse lung organoid models for squamous cell lung cancers allows for the study of combinatorial immunotherapy. Clin Cancer Res 26:3431–3442. https://doi.org/10.1158/1078-0432.CCR-19-1627

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu YL, Paz-Ares L (2017) Lung cancer: current therapies and new targeted treatments. Lancet 389:299–311. https://doi.org/10.1016/S0140-6736(16)30958-8

Article  PubMed  CAS  Google Scholar 

Huang L, Deng FY, Lei SF (2020) Global correlation analysis for miRNA and protein expression profiles in human peripheral blood mononuclear cells. Mol Biol Rep 47:5295–5304. https://doi.org/10.1007/s11033-020-05608-y

Article  PubMed  CAS  Google Scholar 

Jordan EJ, Kim HR, Arcila ME, Barron D, Chakravarty D, Gao J, Chang MT, Ni A, Kundra R, Jonsson P, Jayakumaran G, Gao SP, Johnsen HC, Hanrahan AJ, Zehir A, Rekhtman N, Ginsberg MS, Li BT, Yu HA, Paik PK, Drilon A, Hellmann MD, Reales DN, Benayed R, Rusch VW, Kris MG, Chaft JE, Baselga J, Taylor BS, Schultz N, Rudin CM, Hyman DM, Berger MF, Solit DB, Ladanyi M, Riely GJ (2017) Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies. Cancer Discov 7:596–609. https://doi.org/10.1158/2159-8290.CD-16-1337

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kim B, Kim SW, Lim JY, Park SJ (2020) NCAPH Is Required for proliferation, migration and invasion of non-small-cell lung cancer cells. Anticancer Res 40:3239–3246. https://doi.org/10.21873/anticanres.14305

Article  PubMed  CAS  Google Scholar 

Kim JH, Youn Y, Kim KT, Jang G, Hwang JH (2019) Non-SMC condensin I complex subunit H mediates mature chromosome condensation and DNA damage in pancreatic cancer cells. Sci Rep 9. https://doi.org/10.1038/s41598-019-54478-3.

Li B, Xiao Q, Shan L, Song Y (2022a) NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway. Cell Cycle 21:427–438. https://doi.org/10.1080/15384101.2021.2021050

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li C, Meng J, Zhang T (2022b) NCAPH is a prognostic biomarker and associated with immune infiltrates in lung adenocarcinoma. Sci Rep 12:9578. https://doi.org/10.1038/s41598-022-12862-6

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu Z, Wang W, Zhou Y, Li L, Zhou W (2023) PSMA1, a poor Prognostic factor, promotes tumor growth in lung squamous cell carcinoma. Dis Markers 2023:5386635. https://doi.org/10.1155/2023/5386635

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu C, Han X, Zhang S, Huang M, Guo B, Zhao Z, Yang S, Jin J, Pu W, Yu H (2024) The role of NCAPH in cancer treatment. Cell Signal 121:111262. https://doi.org/10.1016/j.cellsig.2024.111262

Article  PubMed  CAS  Google Scholar 

Lu H, Shi C, Wang S, Yang C, Wan X, Luo Y, Tian L, Li L (2020) Identification of NCAPH as a biomarker for prognosis of breast cancer. Mol Biol Rep 47:7831–7842. https://doi.org/10.1007/s11033-020-05859-9

Article  PubMed  CAS  Google Scholar 

Meira-Strejevitch CS, Pereira IS, Hippolito DDC, Maia MM, Cruz AB, Gava R, Brandao de Mattos CC, Frederico FB, Siqueira RC, Mattos LC, Pereira-Chioccola VL (2020) Ocular toxoplasmosis associated with up-regulation of miR-155-5p/miR-29c-3p and down-regulation of miR-21-5p/miR-125b-5p. Cytokine 127:154990. https://doi.org/10.1016/j.cyto.2020.154990

Article  PubMed  CAS  Google Scholar 

Meng Q, Dong Y, Tao H, Shi L, Tong L, Tang J, Zhang S, Liu Z (2021) ALK-rearranged squamous cell carcinoma of the lung, Thorac. Cancer 12:1106–1114. https://doi.org/10.1111/1759-7714.13818

Article  CAS  Google Scholar 

Oser MG, Niederst MJ, Sequist LV, Engelman JA (2015) Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol 16:e165-172. https://doi.org/10.1016/S1470-2045(14)71180-5

Article  PubMed  PubMed Central  CAS  Google Scholar 

Paul S, Bravo Vazquez LA, Marquez Nafarrate M, Gutierrez Resendiz AI, Srivastava A, Sharma A (2021) The regulatory activities of microRNAs in non-vascular plants: a mini review. Planta 254:57. https://doi.org/10.1007/s00425-021-03707-z

Article  PubMed  CAS  Google Scholar 

Perez-Moreno P, Brambilla E, Thomas R, Soria JC (2012) Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities. Clin Cancer Res 18:2443–2451. https://doi.org/10.1158/1078-0432.CCR-11-2370

Article  PubMed  CAS  Google Scholar 

Qian Y, Galan-Cobo A, Guijarro I, Dang M, Molkentine D, Poteete A, Zhang F, Wang Q, Wang J, Parra E, Panda A, Fang J, Skoulidis F, Wistuba II, Verma S, Merghoub T, Wolchok JD, Wong KK, DeBerardinis RJ, Minna JD, Vokes NI, Meador CB, Gainor JF, Wang L, Reuben A, Heymach JV (2023) MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma. Cancer Cell. 41:1363-1380 e1367. https://doi.org/10.1016/j.ccell.2023.05.015

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rami-Porta R, Bolejack V, Giroux DJ, Chansky K, Crowley J, Asamura H, Goldstraw P; International Association for the Study of Lung Cancer, A.B.M. Prognostic Factors Committee, I. Participating (2014) The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 9:1618–1624. https://doi.org/10.1097/JTO.0000000000000334

Saliminejad K, KhorramKhorshid HR, SoleymaniFard S, Ghaffari SH (2019) An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 234:5451–5465. https://doi.org/10.1002/jcp.27486

Article  PubMed